BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32299429)

  • 1. Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report.
    Eton EA; Abrams G; Khan NW; Fahim AT
    BMC Ophthalmol; 2020 Apr; 20(1):153. PubMed ID: 32299429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presumed autoimmune retinopathy following chickenpox; a case report.
    Prime Z; Sims J; Danesh-Meyer H
    Int Ophthalmol; 2018 Oct; 38(5):2187-2190. PubMed ID: 28825165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune retinopathy in a patient with smoldering multiple myeloma: a case report.
    Bergman Z; Mohammed T; Schocket L; Aouchiche R; Johnson MA
    Doc Ophthalmol; 2024 Jun; 148(3):167-171. PubMed ID: 38363513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maculopathy in Patients with Monoclonal Gammopathy of Undetermined Significance.
    Smith SJ; Johnson MW; Ober MD; Comer GM; Smith BD
    Ophthalmol Retina; 2020 Mar; 4(3):300-309. PubMed ID: 31753810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal imaging in non-paraneoplastic autoimmune retinopathy.
    Kasongole D; Raval V; Mruthyunjaya P; Narayanan R
    Indian J Ophthalmol; 2019 Jul; 67(7):1171-1173. PubMed ID: 31238443
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretinal antibody- proven autoimmune retinopathy.
    Abraham S; Sudharshan S; Bhende M; Ganesh SK; Gopal S
    Indian J Ophthalmol; 2017 May; 65(5):416-420. PubMed ID: 28574003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SD-OCT and autofluorescence characteristics of autoimmune retinopathy.
    Pepple KL; Cusick M; Jaffe GJ; Mruthyunjaya P
    Br J Ophthalmol; 2013 Feb; 97(2):139-44. PubMed ID: 23221966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.
    Garcia CM; Maleki A; Look-Why S; Manhapra A; Durrani K; Foster CS
    Retin Cases Brief Rep; 2023 Jul; 17(4):384-388. PubMed ID: 34618714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
    Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
    BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Thalassemia Minor Manifesting as Proliferative Retinopathy.
    Stultz RD; Conti FF; Kumar JB; Kotabish E; Schachat A; Ehlers JP; Saunthararajah Y; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):e161-e164. PubMed ID: 30395680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
    Oporto Caroca JI; Oporto Caroca J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia.
    Jønsson V; Svendsen B; Vorstrup S; Krarup C; Schmalbruch H; Thomsen K; Heegaard NH; Wiik A; Hansen MM
    Leukemia; 1996 Feb; 10(2):327-32. PubMed ID: 8637242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging of Bietti's crystalline dystrophy.
    Kumar V; Gadkar A
    Indian J Ophthalmol; 2018 Jul; 66(7):1024-1026. PubMed ID: 29941763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus-19-Associated Retinopathy.
    Conrady CD; Faia LJ; Gregg KS; Rao RC
    Ocul Immunol Inflamm; 2021 May; 29(4):675-676. PubMed ID: 33856276
    [No Abstract]   [Full Text] [Related]  

  • 18. Optical Coherence Tomography Angiography in the Multimodal Imaging Evaluation of Interferon-Associated Retinopathy: A Case Report.
    Mastropasqua L; Borrelli E; Amodei F; Aharrh-Gnama A; Toto L; Mattei PA; Mastropasqua R
    Ophthalmic Surg Lasers Imaging Retina; 2017 Jun; 48(6):498-504. PubMed ID: 28613357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
    Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
    Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.